Latest Distribution News

Mirvac has held its FY27 earnings and distribution guidance after a resilient first quarter, despite a marked moderation in residential activity. Occupancy remained at 97%, development milestones advanced and roughly three-quarters of the $200 million buy-back was complete by 20 October.

Laserbond delivered strong FY26 growth despite higher tungsten costs and soft mining demand, while securing a second Komatsu licensing agreement and a new international collaboration with Metal 7. The company is now positioning lower-tungsten products, new coatings and expanded capacity for a much larger market.

Generation Development Group started FY27 with group funds under management up 29% to $48.1 billion, led by record quarterly inflows at Generation Life and resilient growth at Evidentia. The update also points to new commercial opportunities for Lonsec in investment governance, although it contains no earnings or cash flow figures.

New Murchison Gold will return approximately $27 million to shareholders through its first fully franked dividend, following a strong first operating period at Crown Prince. The 0.25 cents-per-share payment is backed by reported cash generation and forecast flows from Crown Prince and Cloudkicker.

The Australian Taxation Office has confirmed that Mantle Minerals’ $0.001 per share capital return was not a dividend or ordinary income for eligible shareholders. The ruling provides a clearer framework for the capital gains tax treatment of the payment made in November 2025.

CD Private Equity Fund II’s underlying investment vehicle has agreed to sell four mature private equity fund interests for approximately US$6.1 million. The sale is priced at 64% of reported NAV but could lead to a future distribution to CD2 unitholders.

MA Financial delivered strong third-quarter growth across lending, asset management and advisory, while warning that residential property credit conditions have forced a temporary redemption suspension. The group still expects underlying FY26 EPS to be materially higher than FY25.

SEEK has reset the economics of its Growth Fund’s second five-year phase, targeting at least $840 million in investor liquidity and approximately $700 million for itself. The plan reduces fees, separates core from non-core assets and ends further capital contributions from SEEK, but distributions remain dependent on asset sales and market conditions.

Sigma Healthcare has entered FY27 with double-digit Chemist Warehouse sales growth, stronger earnings and a merger integration program targeting $100 million in annual synergies by FY29. The next test is whether store expansion and technology consolidation can convert momentum into durable cash returns.

CurveBeam AI has secured its strongest first-quarter HiRise sales result, gained China regulatory clearance and raised A$7.35 million to fund the next stage of commercialisation. The progress comes alongside lower customer receipts and a reported 4.3 quarters of cash runway.

Atlas Arteria’s proportional toll revenue fell 0.4% in the September quarter excluding foreign exchange, while a proposed French tax package could have added about €210 million to APRR Group costs under 2025 conditions. Stronger US and German traffic provided some offset, but the company remains exposed to weak French light-vehicle demand and uncertain legislation.

PLS has priced US$700 million of senior unsecured notes at an 8.00% coupon, adding a substantial source of funding as the lithium producer prepares for further capital investment. The notes mature in 2032, with settlement expected on 23 October subject to customary conditions.